Compile Data Set for Download or QSAR
Report error Found 532 Enz. Inhib. hit(s) with all data for entry = 9420
TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464755(US10793563, Compound I-92)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464753(US10793563, Compound I-90)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465007(US10793563, Compound I-340)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464774(US10793563, Compound I-110)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465033(US10793563, Compound I-366)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464771(US10793563, Compound I-108)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464770(US10793563, Compound I-107)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465029(US10793563, Compound I-362)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465026(US10793563, Compound I-359)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465027(US10793563, Compound I-360)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464765(US10793563, Compound I-102)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464766(US10793563, Compound I-103)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465025(US10793563, Compound I-358)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464763(US10793563, Compound I-100)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464764(US10793563, Compound I-101)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465020(US10793563, Compound I-353)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465021(US10793563, Compound I-354)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464759(US10793563, Compound I-96)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465018(US10793563, Compound I-351)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465019(US10793563, Compound I-352)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464789(US10793563, Compound I-380)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464790(US10793563, Compound I-484)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465048(US10793563, Compound I-383)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464787(US10793563, Compound I-149)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464788(US10793563, Compound I-202)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464789(US10793563, Compound I-380)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464786(US10793563, Compound I-154)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464778(US10793563, Compound I-114 | US10793563, Compound ...)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464784(US10793563, Compound I-120 | US10793563, Compound ...)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464778(US10793563, Compound I-114 | US10793563, Compound ...)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464781(US10793563, Compound I-117 | US10793563, Compound ...)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465040(US10793563, Compound I-373)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464783(US10793563, Compound I-119)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465041(US10793563, Compound I-374)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464780(US10793563, Compound I-116)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465038(US10793563, Compound I-371)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464781(US10793563, Compound I-117 | US10793563, Compound ...)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465039(US10793563, Compound I-372)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464778(US10793563, Compound I-114 | US10793563, Compound ...)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465036(US10793563, Compound I-369)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464779(US10793563, Compound I-115)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465037(US10793563, Compound I-370)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464776(US10793563, Compound I-112)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464777(US10793563, Compound I-113)
Affinity DataKi: <10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464807(US10793563, Compound I-136)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464778(US10793563, Compound I-114 | US10793563, Compound ...)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464806(US10793563, Compound I-135)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM465055(US10793563, Compound I-390)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464797(US10793563, Compound I-126)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
Merck Patent

US Patent
LigandPNGBDBM464781(US10793563, Compound I-117 | US10793563, Compound ...)
Affinity DataIC50: 10nMAssay Description:An assay buffer containing GCN2 kinase and (RS)7 was prepared. 4.7 μL of this stock solution was placed per well of a black, low volume, 384-wel...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/14/2021
Entry Details
US Patent

Displayed 1 to 50 (of 532 total ) | Next | Last >>
Jump to: